Twist Bioscience Corporation, a core mid-cap growth and value equity company in the life sciences segment of the health care sector, and Curio Genomics, a pioneer in genomics software, today announced ...
Watchmaker Genomics says it will collaborate with Revvity to automate and verify methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx liquid handling workstation. The ...
The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6% ...
CEO Tony Zook highlighted NeoGenomics' commitment to innovation and market expansion, supported by the recent acquisition of Pathline and the development of new oncology products. He stated that ...
INTEGRA Biosciences offers liquid handling solutions and magnetic modules to streamline every stage of NGS sample preparation. These innovative tools help to reduce errors, improve the precision and ...
Partnership delivers advanced reverse transcriptase technology to enhance sensitivity, robustness and reproducibility of molecular analysis in clinical, applied and pharmaceutical applications Promega ...
SOUTH SAN FRANCISCO, Calif. & ANN ARBOR, Mich.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health ...
Despite the flexibility and depth of genomic data provided by NGS workflows compared to microarrays, adoption of NGS in agrigenomics has lagged due to the low cost and familiarity of microarray ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback